BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38572510)

  • 1. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
    Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Dasanayake GS; Darlington DS; Singh G; Pride MC; Monroe WG; Taylor GR; Hunter AN; Roman G; Paris JJ; Tanner EEL
    Adv Sci (Weinh); 2024 Jun; 11(23):e2305484. PubMed ID: 38572510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ionic Liquid Coating-Driven Nanoparticle Delivery to the Brain: Applications for NeuroHIV.
    Hamadani CM; Mahdi F; Merrell A; Flanders J; Cao R; Vashisth P; Pride MC; Hunter AN; Singh G; Roman G; Paris JJ; Tanner EEL
    Res Sq; 2023 Feb; ():. PubMed ID: 36824802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Nanoparticles for Delivery of Therapeutics in CNS Infection.
    DeMarino C; Schwab A; Pleet M; Mathiesen A; Friedman J; El-Hage N; Kashanchi F
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):31-50. PubMed ID: 27372507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood-brain barrier.
    Chaturvedi M; Molino Y; Sreedhar B; Khrestchatisky M; Kaczmarek L
    Int J Nanomedicine; 2014; 9():575-88. PubMed ID: 24531257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery.
    Hamadani CM; Dasanayake GS; Gorniak ME; Pride MC; Monroe W; Chism CM; Heintz R; Jarrett E; Singh G; Edgecomb SX; Tanner EEL
    Nat Protoc; 2023 Aug; 18(8):2509-2557. PubMed ID: 37468651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-avoidant ionic liquid (PAIL)-coated nanoparticles to increase bloodstream circulation and drive biodistribution.
    Hamadani CM; Goetz MJ; Mitragotri S; Tanner EEL
    Sci Adv; 2020 Nov; 6(48):. PubMed ID: 33239302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using microfluidic platforms to develop CNS-targeted polymeric nanoparticles for HIV therapy.
    Martins C; Araújo F; Gomes MJ; Fernandes C; Nunes R; Li W; Santos HA; Borges F; Sarmento B
    Eur J Pharm Biopharm; 2019 May; 138():111-124. PubMed ID: 29397261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved nanoformulation and bio-functionalization of linear-dendritic block copolymers with biocompatible ionic liquids.
    Hamadani CM; Chandrasiri I; Yaddehige ML; Dasanayake GS; Owolabi I; Flynt A; Hossain M; Liberman L; Lodge TP; Werfel TA; Watkins DL; Tanner EEL
    Nanoscale; 2022 Apr; 14(16):6021-6036. PubMed ID: 35362493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Blood Cell Hitchhiking in Whole Blood with Ionic Liquid-Coated PLGA Nanoparticles to Redirect Biodistribution After Intravenous Injection.
    Hamadani CM; Dasanayake GS; Chism CM; Gorniak ME; Monroe WG; Merrell A; Pride MC; Heintz R; Wong K; Hossain M; Taylor G; Edgecomb SX; Jones D; Dhar J; Banka A; Singh G; Vashisth P; Randall J; Darlington DS; Everett J; Jarrett E; Werfel TA; Eniola-Adefeso O; Tanner EEL
    Res Sq; 2023 Jul; ():. PubMed ID: 37502854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery.
    Kulkarni SA; Feng SS
    Pharm Res; 2013 Oct; 30(10):2512-22. PubMed ID: 23314933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system delivery of molecules across the blood-brain barrier.
    Gosselet F; Loiola RA; Roig A; Rosell A; Culot M
    Neurochem Int; 2021 Mar; 144():104952. PubMed ID: 33400964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming the Brain Barriers: From Immune Cells to Nanoparticles.
    Charabati M; Rabanel JM; Ramassamy C; Prat A
    Trends Pharmacol Sci; 2020 Jan; 41(1):42-54. PubMed ID: 31839374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicines for the Treatment of CNS Diseases.
    Reynolds JL; Mahato RI
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):1-5. PubMed ID: 28150132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue.
    Lei C; Davoodi P; Zhan W; Chow PK; Wang CH
    J Pharm Sci; 2019 May; 108(5):1736-1745. PubMed ID: 30552956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approaches for CNS delivery of drugs - nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment.
    Gupta S; Kesarla R; Omri A
    Expert Opin Drug Deliv; 2019 Mar; 16(3):287-300. PubMed ID: 30779602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
    Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
    Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
    Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
    Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based nanocarrier efficiently delivers highly water soluble drug across the blood-brain barrier into brain.
    Dutta L; Mukherjee B; Chakraborty T; Das MK; Mondal L; Bhattacharya S; Gaonkar RH; Debnath MC
    Drug Deliv; 2018 Nov; 25(1):504-516. PubMed ID: 29426257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.